pc-1005
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2014 (NCT02033109)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- HSV-2INHIBITOR
HSV-2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pc-1005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03408899 | Phase 1 | Jun 19, 2018 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02033109 | Phase 1 | May 1, 2014 | Population Council, University of Alabama, Birmingham |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2018 |
| Population Council | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1